VOLUNTARY DISSOLUTION - LIQUIDATION

PDC line Pharma

Export PDF

Company — Voluntary dissolution - liquidation.

Financial year 2024 · Closed on 31/12/2024

Net result-11 M €-90,2 %over 1 year

Gross margin2,9 M €+701,5 %over 1 year

Equity-7,8 M €-343,0 %over 1 year

Workforce22,4 ETP+18,5 %over 1 year

Identity

Source · BCE/KBO

PDC line Pharma is a Public limited company incorporated in 2016. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Liège. It employs on average 22,4 ETP workers (FTE).

Legal situation: Voluntary dissolution - liquidation
BCE/KBO no. / VAT: BE 0657.842.221
Incorporation: 30/06/2016
Legal form: Public limited company
Registered office: Rue Louvrex 55-57
4000 Liège · WallonieSee on map
Contributed capital: 1 155 172,00 €
Latest accounts: 31/12/2024
Average workforce: 22,4 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology

Joint committees (1)

Signals

Good liquidityPositive cashflowHealthy social debts

Financials

Source · NBB, 10 filings

Trend over 8 financial years

	2024		2023		2022		2021		2019
Income statement
Gross margin	2,9 M €	+701%	-483 k €	+19.3%	-598,8 k €	-831%	81,9 k €	-91.9%	1 M €
EBITDA	-1,3 M €	+51.5%	-2,6 M €	-19.0%	-2,2 M €	-22.8%	-1,8 M €	-4145%	-42,1 k €
Operating result	-16,6 M €	-67.3%	-9,9 M €	-22.1%	-8,1 M €	-2.6%	-7,9 M €	-105%	-3,9 M €
Net result	-11 M €	-90.2%	-5,8 M €	+3.1%	-6 M €	-12.8%	-5,3 M €	-98.4%	-2,7 M €
Balance sheet
Equity	-7,8 M €	-343%	3,2 M €	-64.3%	9 M €	-56.8%	20,8 M €	+17.8%	17,7 M €
Total assets	3,8 M €	-69.9%	12,5 M €	-31.0%	18,1 M €	-33.4%	27,2 M €	+28.6%	21,1 M €
Cash	2,8 M €	+12.6%	2,5 M €	-77.8%	11,1 M €	+1.9%	10,9 M €	-17.4%	13,2 M €
Debts	6,1 M €	-33.6%	9,2 M €	+1.3%	9,1 M €	+52.4%	5,9 M €	+73.0%	3,4 M €
Other
Workforce	22,4 ETP	+18.5%	18,9 ETP	+23.5%	15,3 ETP	+7.7%	14,2 ETP	+9.2%	13,0 ETP

Board of directors

Source · NBB, accounts to 31/12/2024

9 active

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Alain HERRERA	Director07/07/2016 → 15/11/2027
CarKath0811.816.556Represented by Eric HALIOUA	Managing director27/06/2016 → 15/11/2027
Joël PLUMAS	Director27/06/2016 → 15/11/2027
JPP CONSULTING0829.890.923Represented by Jean-Paul PRIEELS	Director07/07/2016 → 15/11/2027
Laurent LEVY	Director27/06/2016 → 15/11/2027
Lee SANGWOO	Director19/12/2019 → 15/11/2027
Mondher MAHJOUBI	Chairman of the board of directors16/11/2021 → 15/11/2027Director25/05/2020 → 2020 accountsended
NOSHAQ PARTNERS0808.219.836Represented by Patrick STRAGIER	Director07/07/2016 → 15/11/2027
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT0253.445.063Represented by François FONTAINE	Director25/07/2017 → 15/11/2027

Other companies at this address

Rue Louvrex 55-57 4000 Liège

Company	CBE no.
Agence locale pour l'Emploi de Villers-le-Bouillet● Liquidation	0455.591.479
BCH HILL● Liquidation	0700.301.594
CR AVOCAT Société d’avocats● Active	0688.854.507
ERGOCONSULT● Liquidation	0651.772.001
EXIMPA● Liquidation	0414.865.832
FHL AVOCAT● Active	0789.713.919
GROUPE MOSAL● Active	0715.620.369
HEDERA 22● Liquidation	0630.923.236
IMMOSAL● Active	0707.919.559
Isosystems● Liquidation	0873.988.014
LASERFLASH● Liquidation	0447.621.346
LAURENT SCHREIBER AVOCAT● Active	1011.066.830
LM GESTION● Active	0430.928.834
MG Legal société d'avocats● Active	0556.751.987
MOSAL● Active	0827.814.133
QUALIBLOOD● Liquidation	0684.698.353
SPARX INDUSTRIES● Liquidation	0476.423.022
THERATOPIX PHARMA● Liquidation	0738.446.251
VINCENT LAMBERTS AVOCAT● Active	0686.711.005
VM Avocat● Active	0785.439.187

Full financial information

Source · NBB

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	26/08/2025	28/06/2024	18/06/2023	07/06/2022	23/06/2021	24/06/2020
General meeting	30/06/2025	24/06/2024	23/05/2023	19/05/2022	19/05/2021	25/05/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 10 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	30/06/2025	26/08/2025	French	PDF
Abridged model	31/12/2023	24/06/2024	28/06/2024	French	PDF
Abridged model	31/12/2022	23/05/2023	18/06/2023	French	PDF
Abridged model	31/12/2021	19/05/2022	07/06/2022	French	PDF
Abridged model	31/12/2020	19/05/2021	23/06/2021	French	PDF
Abridged model	31/12/2019	25/05/2020	24/06/2020	French	PDF
Abridged modelCorrection	31/12/2018	16/05/2019	02/09/2019	French	PDF
Abridged model	31/12/2018	16/05/2019	18/06/2019	French	PDF
Abridged model	31/12/2017	17/05/2018	02/07/2018	French	PDF
Abridged model	31/12/2016	18/05/2017	23/08/2017	French	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

9 active

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Alain HERRERA	Director07/07/2016 → 15/11/2027
CarKath0811.816.556Represented by Eric HALIOUA	Managing director27/06/2016 → 15/11/2027
Joël PLUMAS	Director27/06/2016 → 15/11/2027
JPP CONSULTING0829.890.923Represented by Jean-Paul PRIEELS	Director07/07/2016 → 15/11/2027
Laurent LEVY	Director27/06/2016 → 15/11/2027
Lee SANGWOO	Director19/12/2019 → 15/11/2027
Mondher MAHJOUBI	Chairman of the board of directors16/11/2021 → 15/11/2027Director25/05/2020 → 2020 accountsended
NOSHAQ PARTNERS0808.219.836Represented by Patrick STRAGIER	Director07/07/2016 → 15/11/2027
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT0253.445.063Represented by François FONTAINE	Director25/07/2017 → 15/11/2027

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Registered office04/12/2025
SIEGE SOCIAL
PDF
Mandates26/08/2025
RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...) - DEMISSIONS, NOMINATIONS
PDF
Mandates21/06/2024
DEMISSIONS, NOMINATIONS
PDF
Other15/04/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Other11/01/2024
DIVERS
PDF
Mandates14/12/2023
DEMISSIONS, NOMINATIONS
PDF
Capital / shares04/07/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Registered office09/06/2023
SIEGE SOCIAL
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings8 filings

Mandates

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

NOSHAQ PARTNERS

CarKath

JPP CONSULTING

Joël PLUMAS

Lee SANGWOO

Alain HERRERA

Mondher MAHJOUBI

Laurent LEVY

20162017201820192020202120222023202420252026

PDC line Pharma

Boulevard de Patience et Beaujonc 3 bte 6, 4000 LiègeAvenue de l'Hôpital 11, 4000 Liège

Director

Managing director

Director

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Louvrex 55-57, 4000 LiègeCurrent		CBE
Boulevard de Patience et Beaujonc 3 bte 6, 4000 Liège	accounts 2023 → 2024	Accounts 2024 · 2025-00414646
Avenue de l'Hôpital 11, 4000 Liège	accounts 2021 → 2022	Accounts 2022 · 2023-00153878

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
PDC line PharmaCurrent	accounts 2021 → 2024	Accounts 2024 · 2025-00414646

Events

2024
Annual accounts 2024-11 M €↓
2023
Annual accounts 2023-5,8 M €↑
2022
Annual accounts 2022-6 M €↓
2021
Annual accounts 2021-5,3 M €↓
2019
Annual accounts 2019-2,7 M €↓
2018
Annual accounts 2018-2,4 M €↓
2017
Annual accounts 2017-2,3 M €↓
2016
Annual accounts 2016-157,8 k €
30/06/2016
IncorporationPublic limited company

PDC line Pharma

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events